Chevy Chase Trust’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.5M Sell
77,166
-3,876
-5% -$1.95M 0.11% 172
2025
Q4
$37.8M Sell
81,042
-2,622
-3% -$1.22M 0.1% 166
2025
Q3
$35.7M Sell
83,664
-7,907
-9% -$3.06M 0.1% 179
2025
Q2
$35.1M Sell
91,571
-2,258
-2% -$814K 0.1% 182
2025
Q1
$32.4M Sell
93,829
-1,925
-2% -$619K 0.1% 178
2024
Q4
$28.7M Sell
95,754
-3,927
-4% -$1.37M 0.09% 199
2024
Q3
$40.5M Sell
99,681
-6,186
-6% -$2.26M 0.12% 155
2024
Q2
$34M Sell
105,867
-3,859
-4% -$1.25M 0.11% 169
2024
Q1
$36.6M Sell
109,726
-918
-0.8% -$281K 0.12% 164
2023
Q4
$29.9M Sell
110,644
-2,506
-2% -$619K 0.11% 174
2023
Q3
$27.8M Sell
113,150
-5,556
-5% -$1.52M 0.11% 171
2023
Q2
$36M Sell
118,706
-4,529
-4% -$1.26M 0.13% 145
2023
Q1
$32.5M Buy
123,235
+1,243
+1% +$316K 0.13% 150
2022
Q4
$29.3M Sell
121,992
-9,454
-7% -$2.12M 0.12% 167
2022
Q3
$24.2M Sell
131,446
-5,956
-4% -$1.19M 0.1% 186
2022
Q2
$23.1M Sell
137,402
-6,607
-5% -$1.42M 0.1% 201
2022
Q1
$36.1M Buy
144,009
+383
+0.3% +$96.2K 0.12% 163
2021
Q4
$36.9M Sell
143,626
-7,730
-5% -$1.89M 0.12% 160
2021
Q3
$36.7M Sell
151,356
-16,110
-10% -$3.94M 0.13% 158
2021
Q2
$34.6M Sell
167,466
-10,479
-6% -$2.14M 0.12% 168
2021
Q1
$33.5M Sell
177,945
-12,046
-6% -$2.12M 0.12% 171
2020
Q4
$31.2M Sell
189,991
-5,561
-3% -$813K 0.11% 170
2020
Q3
$24.4M Sell
195,552
-16,400
-8% -$2.03M 0.1% 190
2020
Q2
$20.6M Sell
211,952
-12,936
-6% -$1.34M 0.08% 222
2020
Q1
$20.2M Buy
224,888
+3,820
+2% +$495K 0.09% 200
2019
Q4
$32.7M Sell
221,068
-1,033
-0.5% -$139K 0.12% 181
2019
Q3
$26.7M Sell
222,101
-1,450
-0.6% -$187K 0.11% 202
2019
Q2
$30.2M Buy
223,551
+176
+0.1% +$22.3K 0.13% 179
2019
Q1
$28.4M Buy
223,375
+1,717
+0.8% +$231K 0.12% 187
2018
Q4
$27.6M Sell
221,658
-691
-0.3% -$92.7K 0.13% 167
2018
Q3
$30.9M Sell
222,349
-13,470
-6% -$1.68M 0.13% 174
2018
Q2
$24.2M Sell
235,819
-1,505
-0.6% -$152K 0.1% 215
2018
Q1
$23M Sell
237,324
-8,823
-4% -$856K 0.1% 223
2017
Q4
$21.6M Sell
246,147
-6,688
-3% -$537K 0.09% 245
2017
Q3
$20.1M Buy
252,835
+5,147
+2% +$414K 0.09% 258
2017
Q2
$21.6M Sell
247,688
-1,700
-0.7% -$144K 0.1% 229
2017
Q1
$22.2M Buy
249,388
+4,680
+2% +$390K 0.11% 223
2016
Q4
$18.1M Sell
244,708
-2,538
-1% -$190K 0.1% 240
2016
Q3
$18.7M Sell
247,246
-10,469
-4% -$802K 0.1% 231
2016
Q2
$19.8M Sell
257,715
-847
-0.3% -$66.9K 0.11% 216
2016
Q1
$20.2M Sell
258,562
-692
-0.3% -$48.3K 0.12% 206
2015
Q4
$17.5M Sell
259,254
-3,000
-1% -$209K 0.1% 231
2015
Q3
$20.3M Buy
262,254
+32,489
+14% +$2.88M 0.13% 196
2015
Q2
$20.8M Sell
229,765
-301
-0.1% -$24.1K 0.12% 202
2015
Q1
$17.3M Buy
+230,066
New +$16.5M 0.1% 235

Other funds holding HCA

Chevy Chase Trust's HCA Position: Q1 2026 in Review

Chevy Chase Trust reduced its HCA Healthcare (HCA) stake by 4.8% in Q1 2026, selling an estimated $1.95M and leaving 77,166 shares worth $36.5M. The position accounts for 0.11% of the portfolio, ranked #172.

Chevy Chase Trust first reported a position in HCA in Q1 2015 and has held it in 45 quarters since. The position peaked at $40.5M in Q3 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Chevy Chase Trust held 77,166 shares of HCA Healthcare worth $36.5M as of Q1 2026.
  • Chevy Chase Trust sold 3,876 HCA Healthcare shares in Q1 2026, an estimated $1.95M.
  • HCA Healthcare made up 0.11% of Chevy Chase Trust's portfolio in Q1 2026, its #172 holding.
  • Chevy Chase Trust first reported a position in HCA Healthcare in Q1 2015 and has held it in 45 quarters since.
  • Chevy Chase Trust's HCA Healthcare position peaked at $40.5M in Q3 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.